Search
for
Sort by
Research 601–630 of 1000+
- Revision for unsatisfactory outcomes of scalp micropigmentation
- Non-invasive assessment of hair regeneration in androgenetic alopecia mice in vivo using two-photon and second harmonic generation imaging
- 518 Nutrient and stress sensing as novel physiological regulator of human hair pigmentation and greying: Role of mTORC1 activity
- 586 Interest of Silybum marianum extract, Manganese PCA and Lespedeza capitata extract in a new anti-hair loss serum to stimulate hair growth and prolong anagen phase
- 1350 Human scalp skin as an abundant and accessible source for eccrine sweat gland isolation and organ culture
- Phytoconstituent Based Formulations and Phenolic Compounds in Acne Management with A Comprehensive Review of Traditional Remedies, Modern Strategies, and Therapeutic Innovations
- Dopamine is a novel, direct inducer of catagen in human scalp hair follicles<i>in vitro</i>
- I‐Ascorbic acid 2‐phosphate represses the dihydrotestosterone‐induced dickkopf‐1 expression in human balding dermal papilla cells
- Phenotyping mice with skin, hair, or nail abnormalities: A systematic approach and methodologies from simple to complex
- Phytotherapeutic Potential of Rosemary in Hair Growth and Hair Fall Prevention: Mechanisms, Efficacy, and Future Perspectives
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- The reasons and solutions for lipsotrichia and pelada phenomenon
- Dandruff lesional scalp skin exhibits epidermal T cell infiltration and a weakened hair follicle immune privilege
- Loose anagen hair of childhood: The phenomenon of easily pluckable hair
- ONION PEEL OIL: TRADITIONAL TOUCH TO THE SCALP
- Alopecia Areata With an FFA ‐Like Phenotype: Clinicopathologic Features and Treatment Outcomes in a Prospective Cohort
- 27604 Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial
- Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- TU55. EXPLORING THE GENOMIC RELATIONSHIP BETWEEN TWO MAJOR DETERMINANT PHENOTYPES OF PSYCHIATRIC DISORDERS: HUMAN GUT MICROBIOME AND SLEEP TRAITS
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- 558 The Bacterial Metabolite, Butyrate, Prolongs Anagen and Promotes Autophagy, Mitochondrial Activity, Melanogenesis and Antimicrobial Peptide Production in Human Scalp Hair Follicles
- INHIBITION OF KERATINIZING STRUCTURES BY SYSTEMIC DRUGS
- Classification scale for male and female androgenetic alopecia.
- Highly Efficient Rinse-Off/Leave-On Scalp Care Treatments to Reduce Moderate to Severe Dandruff
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Age‐related changes in scalp biophysical parameters: A comparative analysis of the 20s and 50s age groups
- Scalp Analysis with Multiparametric Ultrasound before and after Application of Cosmetic with Vasoconstrictor Active
- Variación estacional del tricograma en residentes chilenos